Goodlass 4QFY01: What to expect? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Goodlass 4QFY01: What to expect?

Jun 25, 2001

Goodlass Nerolac, the country's second largest paint manufacturer, is set to announce its fourth quarter and FY01 annual results tomorrow. The company had a dismal third quarter with net profits tumbling by more than 47% due to the slow down in the economy and subdued demand for commercial vehicles. Will 4QFY01 be anything different? The chances are bleak. Read on.

(Rs m)9mFY009mFY01change
Sales 3,880 4,361 12.4%
Other Income 69 83 20.4%
Expenditure 3,522 3,965 12.6%
Operating Profit (EBDIT) 358 396 10.7%
Operating Profit Margin (%)9.2%9.1% 
Interest 65 47 -28.5%
Depreciation 89 136 53.7%
Profit before Tax 273 296 8.6%
Tax 80 83 4.4%
Profit after Tax/(Loss) 194 213 10.3%
Net profit margin (%)5.0%4.9% 
No. of Shares (eoy) (m) 15.3 15.3  
Diluted number of shares 15.3 15.3  
Earnings per share* 16.9 18.6  
*(annualised)   

Goodlass reported a 12.4% rise in sales to Rs 4,361 m in the first nine months of FY01. Considering the quarterly performance of the company, it is in line with the industry. The paint industry had a robust first half with sales growing by more than 15%. Both Asian Paints and Goodlass reported a sharp rise in profits coupled with a marginal rise in operating margins. Goodlass reported a 10.6% and 22.8% rise in sales in 1QFY01 and 2QFY01. Operating margins for the first half of FY01 increased by a marked 160 basis to 9.8%.

But the sharp slump in both the commercial (CVs) as well as the passenger car sales did not augur well for the company in 3QFY01 (Goodlass in the key supplier of paint to Telco and Maruti Suzuki). Both sales and margins witnessed significant erosion. While sales declined by a marginal 2.4%, net profits were down by more than 47%. This was primarily on account a 320 basis points drop in operating margins. Sales and operating margins might continue to decline on account of persistant sluggish auto demand even in 4QFY01. The chart below vindicates it. Passenger cars and multi-utility segment have reported a 10.5% drop in production in March 2001 and April 2001 respectively. CV segment continues to suffer from sluggish freight transportation market. Freight market continues to remain stressed on account of a 12 m tonnes drop in agriculture production last year.

Even in the decorative segment, paint demand was affected in the third and fourth quarter due to the earthquake in Gujarat. Keeping these factors in mind, we expect Goodlass to report around 7%-8% growth in sales for FY01. However, higher income and lower interest costs should prevent the bottomline from posting a huge drop despite expectations of around 100 basis points drop in operating margins for FY01.

The stock is trading at Rs 85 at a P/E multiple of 4.5x the annualised first nine months earnings.

Equitymaster requests your view! Post a comment on "Goodlass 4QFY01: What to expect? ". Click here!

  

More Views on News

KANSAI NEROLAC 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of KANSAI NEROLAC for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of KANSAI NEROLAC. Also includes updates on the valuation of KANSAI NEROLAC.

KANSAI NEROLAC Announces Quarterly Results (1QFY22); Net Profit Up 275.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, KANSAI NEROLAC has posted a net profit of Rs 1 bn (up 275.8% YoY). Sales on the other hand came in at Rs 14 bn (up 119.6% YoY). Read on for a complete analysis of KANSAI NEROLAC's quarterly results.

KANSAI NEROLAC Announces Quarterly Results (3QFY21); Net Profit Up 64.6% (Quarterly Result Update)

Feb 2, 2021 | Updated on Feb 2, 2021

For the quarter ended December 2020, KANSAI NEROLAC has posted a net profit of Rs 2 bn (up 64.6% YoY). Sales on the other hand came in at Rs 15 bn (up 18.0% YoY). Read on for a complete analysis of KANSAI NEROLAC's quarterly results.

Asian Paints vs Berger Paints: Which is Better? (Views On News)

Dec 2, 2021

These companies are competing head on to grab the largest pie of a Rs 500 bn market.

Asian Paints Touches Record High After Stellar Quarterly Results (Views On News)

Jul 22, 2021

Asian Paints shares scaled fresh 52-week high today, before paring gains as the company's topline soared 91.1%.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KANSAI NEROLAC SHARE PRICE


Dec 3, 2021 (Close)

TRACK KANSAI NEROLAC

  • Track your investment in KANSAI NEROLAC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KANSAI NEROLAC

KANSAI NEROLAC - ASIAN PAINTS COMPARISON

COMPARE KANSAI NEROLAC WITH

MARKET STATS